These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The use of felbamate in patients with periodic lateralized epileptiform discharges (PLEDs). Hughes JR; Fuller T Clin Electroencephalogr; 1995 Jul; 26(3):180-3. PubMed ID: 7554306 [TBL] [Abstract][Full Text] [Related]
25. From the Food and Drug Administration. Nightingale SL JAMA; 1993 Oct; 270(14):1672. PubMed ID: 8411485 [No Abstract] [Full Text] [Related]
27. Criteria for use of felbamate in adult, adolescent, and child inpatients and outpatients. Luer MS Am J Hosp Pharm; 1994 Jul; 51(13):1701-3; Quiz 1704-5. PubMed ID: 7942896 [No Abstract] [Full Text] [Related]
29. Felbamate: consensus of current clinical experience. Pellock JM; Faught E; Leppik IE; Shinnar S; Zupanc ML Epilepsy Res; 2006 Oct; 71(2-3):89-101. PubMed ID: 16889941 [TBL] [Abstract][Full Text] [Related]
30. [Felbamate: perspectives for new antiepileptic treatment]. Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622 [TBL] [Abstract][Full Text] [Related]
31. Re: Mazarati et al. "...clinically available [antiepileptic drug] with a moderate affinity for the glycine site of the N-methyl-D-aspartate (NMDA) receptor". Rogawski MA; Wasterlain CG; Mazarati AM Epilepsia; 2000 Jul; 41(7):918-9. PubMed ID: 10897169 [No Abstract] [Full Text] [Related]
32. Felbamate in epilepsy therapy: evaluating the risks. Pellock JM Drug Saf; 1999 Sep; 21(3):225-39. PubMed ID: 10487399 [TBL] [Abstract][Full Text] [Related]
33. [Felbamate: a long-term study in subjects with refractory epilepsy]. De Romanis F; Sopranzi N Clin Ter; 1997 Mar; 148(3):83-7. PubMed ID: 9377844 [TBL] [Abstract][Full Text] [Related]
35. Neuropsychiatric side effects related to treatment with felbamate. McConnell H; Snyder PJ; Duffy JD; Weilburg J; Valeriano J; Brillman J; Cress K; Cavalier J J Neuropsychiatry Clin Neurosci; 1996; 8(3):341-6. PubMed ID: 8854308 [TBL] [Abstract][Full Text] [Related]
36. Antagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam. Serra M; Cuccu R; Ghiani CA; Pisu MG; Murgia A; Biggio G Neurochem Res; 1997 Jun; 22(6):693-7. PubMed ID: 9178952 [TBL] [Abstract][Full Text] [Related]
37. Toxic epidermal necrolysis after initiation of felbamate therapy. Travaglini MT; Morrison RC; Ackerman BH; Haith LR; Patton ML Pharmacotherapy; 1995; 15(2):260-4. PubMed ID: 7624275 [TBL] [Abstract][Full Text] [Related]
38. Felbamate: a double-blind controlled trial in patients undergoing presurgical evaluation of partial seizures. Bourgeois B; Leppik IE; Sackellares JC; Laxer K; Lesser R; Messenheimer JA; Kramer LD; Kamin M; Rosenberg A Neurology; 1993 Apr; 43(4):693-6. PubMed ID: 8469324 [TBL] [Abstract][Full Text] [Related]
39. The new antiepileptic drugs. Appleton RE Arch Dis Child; 1996 Sep; 75(3):256-62. PubMed ID: 8976672 [No Abstract] [Full Text] [Related]
40. Efficacy and safety of felbamate in children with refractory epilepsy. Heyman E; Levin N; Lahat E; Epstein O; Gandelman-Marton R Eur J Paediatr Neurol; 2014 Nov; 18(6):658-62. PubMed ID: 24906615 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]